Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.

@article{Belknap2015AdverseER,
  title={Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.},
  author={Steven M. Belknap and Imran Aslam and Tina Kiguradze and William H. Temps and Paul R. Yarnold and John Cashy and Robert E. Brannigan and Giuseppe Micali and Beatrice Nardone and Dennis P. West},
  journal={JAMA dermatology},
  year={2015},
  volume={151 6},
  pages={600-6}
}
IMPORTANCE Two meta-analyses conclude that finasteride treatment of androgenic alopecia (AGA) is safe but do not assess quality of safety reporting. OBJECTIVE To assess safety reporting for clinical trial reports of finasteride for AGA. DATA SOURCES MEDLINE, ClinicalTrials.gov, and a clinical data repository for an academic medical center. STUDY SELECTION Published clinical trial reports for finasteride treatment of AGA. DATA EXTRACTION AND SYNTHESIS For each trial, we assessed quality… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

Similar Papers

Loading similar papers…